Your browser doesn't support javascript.
loading
The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides.
Tajti, Gabor; Wai, Dorothy C C; Panyi, Gyorgy; Norton, Raymond S.
Affiliation
  • Tajti G; Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Wai DCC; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia.
  • Panyi G; Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. Electronic address: panyi@med.unideb.hu.
  • Norton RS; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia; ARC Centre for Fragment-Based Design, Monash University, Parkville, VIC 3052, Australia. Electronic address: ray.norton@monash.edu.
Biochem Pharmacol ; 181: 114146, 2020 11.
Article in En | MEDLINE | ID: mdl-32653588
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Potassium Channel Blockers / Kv1.3 Potassium Channel / Molecular Targeted Therapy Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Biochem Pharmacol Year: 2020 Document type: Article Affiliation country: Hungary Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Potassium Channel Blockers / Kv1.3 Potassium Channel / Molecular Targeted Therapy Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Biochem Pharmacol Year: 2020 Document type: Article Affiliation country: Hungary Country of publication: United kingdom